Pharmacokinetic (PK) Characterization of Subcutaneous Tulisokibart (MK-7240-010)
Clinical trial NCT06575595 · COMPLETED
Trial details
- NCT number
- NCT06575595
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-24
- Primary completion
- 2025-01-31
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.